선천성 갑상샘 저하증의 분자유전학적 측면
Molecular Aspects of Congenital Hypothyroidism
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Recent studies have identified molecular genetic defects in some cases of congenital hypothyroidism as well as in a few cases of central hypothyroidism. These studies have brought to light hitherto unexplained forms of both these disorders. In spite of early diagnosis by screening of newborns infants and early treatment, some patients with congenital hypothyroidism do not show normal mental development. This finding was subsequently attributed to molecular defects in transcription factors, which are important for both the embryonic development of the thyroid gland as well as the development of other organs, including the organs of the central nervous system (CNS). These findings will facilitate the understanding of the critical role of thyroid hormones in pre- and postnatal CNS development. However, the molecular basis of thyroid dysgenesis in most cases remains to be elucidated, and the identification and analysis of familial cases will be very useful for defining additional mechanisms of thyroid dysgenesis. In fact, these studies may provide crucial evidence for genetic counseling, as suggested by the possible dominant mode of inheritance of some forms of congenital hypothyroidism. This review focuses on the most recent advance in our understanding of the molecular basis of primary congenital hypothyroidism.
Abstract
Recent studies have identified molecular genetic defects in some cases of congenital hypothyroidism as well as in a few cases of central hypothyroidism. These studies have brought to light hitherto unexplained forms of both these disorders. In spite of early diagnosis by screening of newborns infants and early treatment, some patients with congenital hypothyroidism do not show normal mental development. This finding was subsequently attributed to molecular defects in transcription factors, which are important for both the embryonic development of the thyroid gland as well as the development of other organs, including the organs of the central nervous system (CNS). These findings will facilitate the understanding of the critical role of thyroid hormones in pre- and postnatal CNS development. However, the molecular basis of thyroid dysgenesis in most cases remains to be elucidated, and the identification and analysis of familial cases will be very useful for defining additional mechanisms of thyroid dysgenesis. In fact, these studies may provide crucial evidence for genetic counseling, as suggested by the possible dominant mode of inheritance of some forms of congenital hypothyroidism. This review focuses on the most recent advance in our understanding of the molecular basis of primary congenital hypothyroidism.
참고문헌 (42)
- Kratzsch J, "Thyroid gland development and defects", Best Pract Res Clin Endocrinol Metab, 22, pp.57~75 (2008)
- Van Vliet G, "Development of the thyroid gland: lessons from congenitally hypothyroid mice and men", Clin Genet, 63, pp.445~455 (2003)
- Van Vliet G, "Treatment of congenital hypothyroidism", Lancet, 358, pp.86~87 (2001)
- "New England Congenital Hypothyroidism Collaborative. Effects of neonatal screening for hypothyroidism: prevention of mental retardation by treatment before clinical manifestations", Lancet, 2, pp.1095~1098 (1981)
- Grüters A, "Molecular genetic defects in congenital hypothyroidism", Eur J Endocrinol, 151(3), pp.U39~U44 (2004)
- Collu R, "A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene", J Clin Endocrinol Metab, 82, pp.1561~1565 (1997)
- Castanet M, "AFDPHE (Association Française pour le Dépistage et la Prévention des Handicaps de l'Enfant). Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors", J Clin Endocrinol Metab, 86, pp.2009~2014 (2001)
- Sunthornthepvarakul Y, "Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene", N Engl J Med, 332, pp.155~160 (1995)
- Trueba SS, "PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations", J Clin Endocrinol Metab, 90, pp.455~462 (2005)
- Kimura S, "The T", ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary, 1996, pp.10, 60~69
- Pohlenz J, "Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice", J Clin Invest, 109, pp.469~473 (2002)
- Castanet M, "A novel loss- of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis, and cleft palate", Hum Mol Gen, 11, pp.2051~2059 (2002)
- Macchia PE, "Cloning, chromosomal localization and identification of polymorphisms in the human thyroid transcription factor 2 gene (TITF2)", Biochimie, 81, pp.433~440
- Vilain C, "Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8", J Clin Endocrinol Metab, 86, pp.234~238 (2001)
- Congdon T, "A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child", J Clin Endocrinol Metab, 86, pp.3962~3967 (2001)
- Tonacchera M, "Genetic analysis of the PAX8 gene in children with congenital hypothyroidism and dysgenetic or eutopic thyroid glands: identification of a novel sequence variant", Clin Endocrinol, 67, pp.34~40 (2007)
- Macchia PE, "PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis", Nat Genet, 19, pp.83~86 (1998)
- Al Taji E, "Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism", Eur J Endocrinol, 156, pp.521~529 (2007)
- Weinstein LS, "Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting", Endocr Rev, 22, pp.675~705 (2001)
- De La Vieja A, "Molecular analysis of the sodium", iodide symporter: impact on thyroid and extrathyroid pathophysiology, 2000, pp.80, 1083~1105
- Rodrigues C, "Mutation screening of the thyroid peroxidase gene in a cohort of 55 Portuguese patients with congenital hypothyroidism", Eur J Endocrinol, 152, pp.193~198 (2005)
- Bakker B, "Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update)", J Clin Endocrinol Metab, 85, pp.3708~3712 (2000)
- Tenenbaum-Rakover Y, "Clinical and genetic characteristics of congenital hypothyroidism due to mutations in the thyroid peroxidase (TPO) gene in Israelis", Clin Endocrinol, 66, pp.695~702 (2007)
- Kopp P, "Pendred's syndrome and genetic defects in thyroid hormone synthesis", Rev Endocr Metab Disord, 1(1), pp.109~121 (2000)
- Gonzalez Trevino O, "Clinical and molecular analysis of three Mexican families with Pendred's syndrome", Eur J Endocrinol, 144, pp.585~593 (2001)
- Borck G, "Genetic causes of goiter and deafness: Pendred syndrome in a girl and cooccurrence of Pendred syndrome and resistance to thyroid hormone in her sister", J Clin Endocrinol Metab, 94, pp.2106~2109 (2009)
- Kopp P, "Pendred syndrome and iodide transport in the thyroid", Trends Endocrinol Metab, 19, pp.260~268 (2008)
- Moreno JC, "Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism", N Engl J Med, 347, pp.95~102 (2002)
- Dumitrescu AM, "A novel syndrome combining thyroid and neurological abnormalities is associated with mutation sin a monocarboxylase transporter gene", Am J Hum Genet, 74, pp.168~175 (2004)
- van der Deure WM, "Genetic variation in thyroid hormone transporters", Best Pract Res Clin Endocrinol Metab, 21, pp.339~350 (2007)
- Heuer H, "Minireview: Pathophysiological importance of thyroid hormone transporters", Endocrinology, 150, pp.1078~1083 (2009)
- Grüters A, "Thyroid hormone transporter defects", Endocr Dev, 10, pp.118~126 (2007)
- Katakami H, "Hypothalamic hypothyroidism due to isolated thyrotropin-releasing hormone (TRH) deficiency", J Endocrinol Invest, 7, pp.231~233 (1984)
- Pohlenz J, "Congenital secondary hypothyroidism caused by exon skipping due to a homozygous donor splice site mutation in the TSH β-subunit gene", J Clin Endocrinol Metab, 87, pp.336~339 (2002)
- Radovick S, "A mutation in the POU-homeodomain of Pit- 1 responsible for combined pituitary hormone deficiency", Science, 257, pp.1115~1118 (1992)
- Wu W, "Mutations in PROP1 cause familial combined pituitary hormone deficiency", Nat Genet, 18, pp.147~149 (1998)
- Netchine I, "in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency", Nat Genet, 25, pp.182~186 (2000)
- Dattani MT, "Mutations in the homeobox gene HESX1", Hesx1 associated with septo-optic dysplasia in human and mouse, 1998, pp.19, 125~133
- Weiss RE, "Resistance to thyroid hormone", Rev Endocr Metab Disord, (1), pp.97~108 (2001)
- Brucker-Davis F, "Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study", Ann Intern Med, 123, pp.572~583 (1995)
- Park SM, "Genetics of congenital hypothyroidism", J Med Genet, 42, pp.379~389 (2005)
- Kopp P, "Perspective: genetic defects in the etiology of congenital hypothyroidism", Endocrinology, 143, pp.2019~2024 (2002)